Edwards Lifesciences Corporation Common Stock

Afficher le graphique complet Full chart

Financials

Total de l'actif 13.06 B13.02 B13.49 B13.27 B13.7 B13.32 B Total du passif 2.99 B2.83 B2.88 B3.07 B3.36 B2.99 B Total des capitaux propres 10.06 B10.19 B10.61 B10.21 B10.34 B10.33 B Total du passif et des capitaux propres 13.06 B13.02 B13.49 B13.27 B13.7 B13.32 B Dette totale 597.7 M597.8 M598 M598.2 M598.3 M598.5 M Dette nette 597.7 M597.8 M-3.46 B-3.24 B-3.63 B-3.07 B

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027.

EW

Financials

Edwards Lifesciences Corporation Common Stock

Nouvelles

OPKO Health (OPK) Up 17.1% Since Last Earnings Report: Can It Continue?

Le CVP d’Edwards Lifesciences Donald Bobo Jr. cède 2 M$ d’actions

L’action Edwards Lifesciences atteint un plus haut sur 52 semaines à 87,89 USD

Boston Scientific Bets on WATCHMAN to Drive Structural Heart Growth

S&P 500 Top Stock Gainers Today, 5/22/26 - TipRanks.com

Are Wall Street Analysts Bullish on Edwards Lifesciences Stock?

Edwards Lifesciences Corporation (EW) Presents at Bank of America Global Healthcare Conference 2026 Transcript

Le CVP Wayne Markowitz d’Edwards Lifesciences cède des actions pour 47.279$

Boston Scientific: Poised To Rebound With The Healthcare Sector, But When? (NYSE:BSX)

Le CVP TAVR d’Edwards Lifesciences vend pour 170.160$ d’actions

Edwards Lifesciences nomme Doretta Mistras au poste de directrice financière

Top Research Reports for Philip Morris, Honeywell & Starbucks